Neogen (FRA:NG2) Common Stock: €29.4 Mil (As of Feb. 2026)


FRA:NG2 Neogen Corp FRA:NG2
68 GF Score
Price €8.40
GF Value €10.73
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Neogen Common Stock?

Neogen FRA:NG2 +5.08% 68 Common Stock is €29.4 Mil as of Feb. 2026. GuruFocus rates FRA:NG2 with a GF Score™ of 68/100 and a GF Value™ of €10.73 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Neogen's quarterly common stock increased from Aug. 2025 (€29.9 Mil) to Nov. 2025 (€30.1 Mil) but then declined from Nov. 2025 (€30.1 Mil) to Feb. 2026 (€29.4 Mil).

Neogen's annual common stock increased from May. 2023 (€31.8 Mil) to May. 2024 (€32.1 Mil) but then declined from May. 2024 (€32.1 Mil) to May. 2025 (€30.8 Mil).

Neogen Common Stock Historical Data

* Premium members only.

The historical data trend for Neogen's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neogen Common Stock Chart

Neogen Annual Data
Trend May16 May17 May18 May19 May20 May21 May22 May23 May24 May25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.15 16.32 31.83 32.06 30.80

Neogen Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.34 30.80 29.87 30.11 29.44
FRA:NG2
68GF Score
Neogen Corp FRA:NG2
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Neogen Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of €29.4 Mil mean?
Neogen (FRA:NG2) has a Common Stock of €29.4 Mil as of Feb. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Neogen and its competitors.
Is Neogen's Common Stock too high?
Neogen's current Common Stock is €29.4 Mil. Overall, Neogen has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Neogen's Common Stock compare to UFPT and ALMR?
Neogen's Common Stock of €29.4 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Devices & Instruments company?
A good Common Stock depends on the Medical Devices & Instruments industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Neogen and its competitors. Neogen's current Common Stock is €29.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neogen stock overvalued right now?
Based on GuruFocus' analysis, Neogen (FRA:NG2) is currently considered Modestly Undervalued. The stock's GF Value™ is €10.73, compared to a current price of €8.40 — trading 21.8% below its estimated fair value. The current Common Stock is €29.4 Mil. Neogen's overall GF Score™ is 68/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Neogen (FRA:NG2), the current Common Stock is €29.4 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Neogen (FRA:NG2) Overvalued in 2026?

Based on GuruFocus' analysis, Neogen stock appears to be undervalued. The current stock price of €8.40 is trading 21.8% below its estimated GF Value™ of €10.73. GuruFocus considers Neogen to be Modestly Undervalued.

Key valuation signals for FRA:NG2:

  • Common Stock: €29.4 Mil
  • GF Value™: €10.73 vs. price of €8.40 (21.8% below fair value)
  • GF Score™: 68/100 with 3 warning signs

No single metric tells the full story. See the FRA:NG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Neogen Business Description

Other Exchanges NEOG:USANG2:Germany
Address 620 Lesher Place, Lansing, MI, USA, 48912
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
68GF Score

Get the complete analysis for FRA:NG2

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€8.40
Price
€10.73
GF Value